|
|
||||||||
Georgetown University Hospital, Washington, D.C.
Correspondence: For reprints contact: John C. Harbert, Dept. of Nuclear Medicine, Georgetown University Hospital, 3800 Reservoir Rd., N.W., Washington, D.C. 20007.
ABSTRACT
Eleven patients treated with 131I for thyroid carcinoma or thyroid ablation and their immediate family members were monitored by film badge for radiation exposure. The results indicated that the current AEC regulation permitting a patient body burden of 30 mCi at time of hospital discharge is conservative.
This article has been cited by other articles:
![]() |
G. S. Pant, S. K. Sharma, C. S. Bal, R. Kumar, and G. K. Rath Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I Radiat Prot Dosimetry, April 1, 2006; 118(1): 22 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Rutar, S. C. Augustine, D. Colcher, J. A. Siegel, D. A. Jacobson, M. A. Tempero, V. J. Dukat, M. A. Hohenstein, L. S. Gobar, and J. M. Vose Outpatient Treatment with 131I-Anti-B1 Antibody: Radiation Exposure to Family Members J. Nucl. Med., June 1, 2001; 42(6): 907 - 915. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Grigsby, B. A. Siegel, S. Baker, and J. O. Eichling Radiation Exposure From Outpatient Radioactive Iodine (131I) Therapy for Thyroid Carcinoma JAMA, May 3, 2000; 283(17): 2272 - 2274. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |